Skip to main content
Trending:
No Fast-track for Alzheimer's Drug
Podcast: Staying Patient-Centered
High Deductible Surprise Bills
Toggle navigation
Topics
Pharma
Post-Acute
Technology
Telehealth
Clinical Care
Payer
Strategy
Finance
Revenue Cycle
Innovation
Nursing
Human Resources
Marketing
Supply Chain
COVID-19
Events
Resources
Weekly Wrap Video
HLM Podcasts
Free Webinars
HealthLeaders Magazine
Whitepapers
Fact File
Intelligence Reports
Profile Reports
Exchange Insight Reports
Industry Focus Reports
Roundtable Reports
One Minute Matters Videos
Subscribe
Search form
Enter search term
Pharma
Peptilogics CEO Jonathan Steckbeck Targets Deadly Prosthetic Infections
Personal tragedies involving family and friends motivated this CEO to launch Peptilogics.
The Tests Are Vital. But Congress Decided That Regulation Is Not.
Money and lobbying help shield lab-developed tests, including prenatal screenings, from heightened federal scrutiny.
Amazon Pharmacy Launches Very, Very Low-Cost Prescription Drug Service
RxPass will cost $5 a month for an unlimted supply of ALL commonly used drugs in its generic and off-brand...
Get the latest on healthcare leadership in your inbox.
Subscribe
Advertisement
FDA Rejects Fast-Track Approval of Eli Lilly's New Alzheimer's Drug
Regulators want more evidence that the pricey drug works.
Mich. Woman Convicted in $65M Pharma 'Coupon' Scam
Suzan Berro submitted fake reimbursement claims to several drugmakers' co-pay assistance programs.
What Older Americans Need to Know About Taking Paxlovid
Seek treatment with antiviral therapy, which remains effective against new COVID variants.
Numbers Don't Lie. Biden Kept His Promise on Improving Obamacare.
Observers offer 'an unequivocal yes,' to the question of whether Biden has met his campaign promise.
The Biggest, Buzziest Conference for Healthcare Investors Convenes Amid Fears the Bubble Will Burst
The JPMorgan annual healthcare conference had just as many words about profits as about patients.
CA AG Sues Insulin Makers, PBMs for Price Gouging
Eli Lilly, Novo Nordisk, Sanofi, CVS Caremark, Express Scripts, and OptumRx are accused of overcharging patients.
With rise of new coronavirus variants, FDA halts authorization of Evusheld
The FDA has halted the emergency use authorization of Evusheld because it does not appear to protect against COVID-19 from...
CVS, Walmart to cut pharmacy hours as staffing squeeze continues
Operating schedules remain 'pain point' as chains seek to improve work environment.
Biden growls at the high costs of insulin for people not on Medicare
President Biden, on Thursday, got angry about the price of drugs like insulin preventing some parents from being able to...
Walgreens weighs $2 billion sale of pharmacy automation unit iA
Walgreens Boots Alliance Inc. is weighing a sale of its pharmacy automation business, which could fetch up to $2 billion,...
CDC: Updated boosters are cutting the risk of getting sick from COVID-19 by about half
The updated COVID-19 boosters are cutting the risk that a person will get sick from the coronavirus by about half,...
FDA vaccine advisers to meet to consider the future of COVID-19 vax
A panel of independent experts that advises the FDA on its vaccine decisions will hold a full day of meetings...
Load More